105 related articles for article (PubMed ID: 12213094)
1. Tissue plasminogen activator is released into cultured medium by cultured human uveal melanocytes.
Wang Y; Hu DN; McCormick SA; Savage HE; O'Rourke J
Pigment Cell Res; 2002 Oct; 15(5):373-8. PubMed ID: 12213094
[TBL] [Abstract][Full Text] [Related]
2. Effect of transforming growth factor-beta on plasminogen activator production of cultured human uveal melanoma cells.
Park SS; Li L; Korn TS; Mitra MM; Niederkorn JY
Curr Eye Res; 1996 Jul; 15(7):755-63. PubMed ID: 8670784
[TBL] [Abstract][Full Text] [Related]
3. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro.
Chu SC; Hu DN; Yang SF; Yang PY; Hsieh YS; Huang SM; Yu G; McCormick SA
Pigment Cell Res; 2004 Dec; 17(6):636-42. PubMed ID: 15541021
[TBL] [Abstract][Full Text] [Related]
5. Attachment of human uveal melanocytes and melanoma cells to extracellular matrix proteins involves intracellular calcium and calmodulin.
Wagner M; Bielby S; Rennie IG; Mac Neil S
Melanoma Res; 1997 Dec; 7(6):439-48. PubMed ID: 9464615
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
Bizik J; Lizonová A; Stephens RW; Grófová M; Vaheri A
Cell Regul; 1990 Nov; 1(12):895-905. PubMed ID: 1712633
[TBL] [Abstract][Full Text] [Related]
8. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes.
Hu DN; McCormick SA; Ritch R; Pelton-Henrion K
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2210-9. PubMed ID: 8505203
[TBL] [Abstract][Full Text] [Related]
9. Morphologic evidence for a preferential storage of tissue plasminogen activator (t-PA) in perivascular axons of the rat uvea.
Wang Y; Hand AR; Gillies C; Grunnet ML; Cone RE; O'Rourke J
Exp Eye Res; 1997 Jul; 65(1):105-16. PubMed ID: 9237871
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator secreted by cultured human melanocytes.
Hashimoto K; Horikoshi T; Nishioka K; Yoshikawa K; Carter DM
Br J Dermatol; 1986 Aug; 115(2):205-9. PubMed ID: 3091061
[TBL] [Abstract][Full Text] [Related]
11. Regulation of melanogenesis by human uveal melanocytes in vitro.
Hu DN; McCormick SA; Orlow SJ; Rosemblat S; Lin AY
Exp Eye Res; 1997 Mar; 64(3):397-404. PubMed ID: 9196391
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta2 inhibits growth of uveal melanocytes at physiological concentrations.
Hu DN; McCormick SA; Lin AY; Lin JY
Exp Eye Res; 1998 Aug; 67(2):143-50. PubMed ID: 9733581
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanocytes express high constitutive levels of MMP-8 which can be upregulated by TNF-α via the MAPK pathway.
Hu DN; Rosen RB; Chan CC; Yang WE; Yang SF
Exp Eye Res; 2018 Oct; 175():181-191. PubMed ID: 29935949
[TBL] [Abstract][Full Text] [Related]
14. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells.
Fukushima M; Nakashima Y; Sueishi K
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1576-83. PubMed ID: 2501229
[TBL] [Abstract][Full Text] [Related]
15. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
16. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
[TBL] [Abstract][Full Text] [Related]
17. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
18. The proteolytic potential of normal human melanocytes: comparison with other skin cells and melanoma cell lines.
Bizik J; Bessou S; Felnerova D; Vaheri A; Taïeb A
Pigment Cell Res; 1996 Oct; 9(5):255-64. PubMed ID: 9014212
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
Hayashi K; Nakashima Y; Sueishi K; Tanaka K
Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Waghray A; Webber MM
Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
